Epigenetic regulation of HIF-1α in renal cancer cells involves HIF-1α/2α binding to a reverse hypoxia-response...

Area of Science:

• Oncology
• Molecular Biology
• Epigenetics

Background:

• Von Hippel-Lindau (VHL) gene inactivation is a key driver in clear cell renal cell carcinoma (CCRCC) and VHL cancer syndrome.
• VHL loss leads to stabilized hypoxia-inducible factors (HIF-1α and HIF-2α), promoting tumorigenesis.
• The distinct roles of HIF-1α and HIF-2α in CCRCC progression, particularly the transition from limited to aggressive proliferation, remain unclear.

Purpose of the Study:

• To elucidate the interplay between HIF-1α and HIF-2α subunits in VHL-inactivated CCRCC.
• To investigate the regulatory mechanisms controlling HIF-α subunit expression and their impact on CCRCC cell behavior.
• To explore the role of epigenetic modifications in CCRCC development driven by VHL inactivation.

Main Methods:

• Analysis of VHL-inactivated CCRCC cell lines.
• Investigation of HIF-1α and HIF-2α mRNA and protein expression.
• Chromatin immunoprecipitation assays to assess HIF subunit binding to the HIF-1α promoter.
• Histone modification analysis, including H3K27me3, to evaluate epigenetic changes.

Main Results:

• VHL inactivation in CCRCC cells causes HIF-1α/2α-dependent downregulation of HIF-1α mRNA.
• HIF subunits directly bind to a reverse hypoxia-response element in the HIF-1α promoter, activating repressive histone marks like H3K27me3.
• Reversal of these epigenetic changes leads to excessive HIF-1α expression and reduced CCRCC cell proliferation.

Conclusions:

• HIF-α subunits autoregulate HIF-1α mRNA levels through direct promoter binding and epigenetic modifications.
• Epigenetic mechanisms, specifically H3K27me3, play a crucial role in stabilizing HIF-1α downregulation and influencing CCRCC progression.
• These findings enhance the understanding of HIF-α subunit crosstalk and offer potential therapeutic targets for CCRCC.